Detailed Research: Economic Perspectives on Intersect ENT, Granite Construction, Spok, Regeneron Pharmaceuticals, SunTrust Banks, and Interpublic Group of Companies — What Drives Growth in Today's Competitive Landscape

22-02-2018

NEW YORK, Feb. 22, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Intersect ENT, Inc. (NASDAQ:XENT), Granite Construction Incorporated (NYSE:GVA), Spok Holdings, Inc. (NASDAQ:SPOK), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), SunTrust Banks, Inc. (NYSE:STI), and Interpublic Group of Companies, Inc. (NYSE:IPG), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

XENT DOWNLOAD: https://Fundamental-Markets.com/register/?so=XENT
GVA DOWNLOAD: https://Fundamental-Markets.com/register/?so=GVA
SPOK DOWNLOAD: https://Fundamental-Markets.com/register/?so=SPOK
REGN DOWNLOAD: https://Fundamental-Markets.com/register/?so=REGN
STI DOWNLOAD: https://Fundamental-Markets.com/register/?so=STI
IPG DOWNLOAD: https://Fundamental-Markets.com/register/?so=IPG

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Intersect ENT, Inc. (NASDAQ:XENT), Granite Construction Incorporated (NYSE:GVA), Spok Holdings, Inc. (NASDAQ:SPOK), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), SunTrust Banks, Inc. (NYSE:STI), and Interpublic Group of Companies, Inc. (NYSE:IPG) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 20th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

INTERSECT ENT, INC. (XENT) REPORT OVERVIEW

Intersect ENT's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Intersect ENT reported revenue of $22.31MM vs $18.47MM (up 20.82%) and basic earnings per share -$0.15 vs -$0.22. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Intersect ENT reported revenue of $78.71MM vs $61.59MM (up 27.79%) and basic earnings per share -$0.89 vs -$1.02. Intersect ENT is expected to report earnings on February 27th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.17. The estimated EPS forecast for the next fiscal year is -$0.44 and is expected to report on February 27th, 2018.

To read the full Intersect ENT, Inc. (XENT) report, download it here: https://Fundamental-Markets.com/register/?so=XENT

-----------------------------------------

GRANITE CONSTRUCTION INCORPORATED (GVA) REPORT OVERVIEW

Granite Construction's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Granite Construction reported revenue of $801.27MM vs $666.68MM (up 20.19%) and basic earnings per share $0.84 vs $0.40 (up 110.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Granite Construction reported revenue of $2,989.71MM vs $2,514.62MM (up 18.89%) and basic earnings per share $1.74 vs $1.44 (up 20.83%). Granite Construction is expected to report earnings on May 1st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.60. The estimated EPS forecast for the next fiscal year is $4.10 and is expected to report on February 15th, 2019.

To read the full Granite Construction Incorporated (GVA) report, download it here: https://Fundamental-Markets.com/register/?so=GVA

-----------------------------------------

SPOK HOLDINGS, INC. (SPOK) REPORT OVERVIEW

Spok's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Spok reported revenue of $43.64MM vs $45.36MM (down 3.79%) and basic earnings per share $0.19 vs $0.20 (down 5.00%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Spok reported revenue of $179.56MM vs $189.63MM (down 5.31%) and basic earnings per share $0.68 vs $3.74 (down 81.82%). Spok is expected to report earnings on March 7th, 2018. The report will be for the fiscal period ending December 31st, 2017.

To read the full Spok Holdings, Inc. (SPOK) report, download it here: https://Fundamental-Markets.com/register/?so=SPOK

-----------------------------------------

REGENERON PHARMACEUTICALS, INC. (REGN) REPORT OVERVIEW

Regeneron Pharmaceuticals' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Regeneron Pharmaceuticals reported revenue of $1,582.45MM vs $1,226.83MM (up 28.99%) and basic earnings per share $1.61 vs $2.40 (down 32.92%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Regeneron Pharmaceuticals reported revenue of $5,872.23MM vs $4,860.43MM (up 20.82%) and basic earnings per share $11.27 vs $8.55 (up 31.81%). Regeneron Pharmaceuticals is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $2.16. The estimated EPS forecast for the next fiscal year is $20.07 and is expected to report on February 14th, 2019.

To read the full Regeneron Pharmaceuticals, Inc. (REGN) report, download it here: https://Fundamental-Markets.com/register/?so=REGN

-----------------------------------------

SUNTRUST BANKS, INC. (STI) REPORT OVERVIEW

SunTrust Banks' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, SunTrust Banks reported interest income of $1,640.00MM vs $1,492.00MM (up 9.92%) and basic earnings per share $1.50 vs $0.91 (up 64.84%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, SunTrust Banks reported interest income of $6,387.00MM vs $5,778.00MM (up 10.54%) and basic earnings per share $4.53 vs $3.63 (up 24.79%). SunTrust Banks is expected to report earnings on April 20th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.87. The estimated EPS forecast for the next fiscal year is $5.51 and is expected to report on January 18th, 2019.

To read the full SunTrust Banks, Inc. (STI) report, download it here: https://Fundamental-Markets.com/register/?so=STI

-----------------------------------------

INTERPUBLIC GROUP OF COMPANIES, INC. (IPG) REPORT OVERVIEW

Interpublic Group of Companies' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Interpublic Group of Companies reported revenue of $2,341.00MM vs $2,264.50MM (up 3.38%) and basic earnings per share $0.82 vs $0.81 (up 1.23%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Interpublic Group of Companies reported revenue of $7,882.40MM vs $7,846.60MM (up 0.46%) and basic earnings per share $1.49 vs $1.53 (down 2.61%). Interpublic Group of Companies is expected to report earnings on April 20th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.05. The estimated EPS forecast for the next fiscal year is $1.84 and is expected to report on February 13th, 2019.

To read the full Interpublic Group of Companies, Inc. (IPG) report, download it here: https://Fundamental-Markets.com/register/?so=IPG

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Latest news
Related news
Related shares
Interpublic Group of Companies
VOL 1,096,872
22.28 USD
0.07 / 0.32 %

SunTrust Banks Inc
VOL 880,196
63.07 USD
-1.42 / -2.20 %

Regeneron Pharmaceuticals Inc
VOL 460,365
406.99 USD
-0.61 / -0.15 %

Granite Construction Incorpora
VOL 161,760
46.09 USD
-0.75 / -1.60 %

Intersect ENT Inc
VOL 78,826
33.20 USD
-0.44 / -1.31 %